Document is current
Any future updates will be listed below
-
Authors
Lehto, Annaliis https://orcid.org/0000-0003-3459-8226
Schumacher, Julia https://orcid.org/0000-0001-7323-4789
Kurth, Jens https://orcid.org/0000-0001-6864-4513
Krause, Bernd J.
Kasper, Elisabeth https://orcid.org/0000-0003-0583-1236
Teipel, Stefan https://orcid.org/0000-0002-3586-3194
Prudlo, Johannes https://orcid.org/0000-0002-7932-5929
,
-
Funding
Funding for this research was provided by:
André Greipel and his “Fight ALS” initiative
Boris Canessa ALS Foundation
Bundesministerium für Bildung und Forschung/Verein Deutscher Ingenieure (13GW0482D)
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
- License Information
-
More Information
Article History
Received: 3 January 2025
Revised: 2 April 2025
Accepted: 4 April 2025
First Online: 20 May 2025
Declarations
:
: S.T. served on advisory boards of Lilly, Eisai, and Biogen, and is member of the independent data safety and monitoring board of the ENVISION study (Biogen).
: The study was carried out in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Patients gave their written informed consent, and the study was approved by the local medical ethics committee.
